| 书目名称 | Ocular and Adnexal Lymphoma | | 编辑 | Vishal R. Raval,Prithvi Mruthyunjaya,Arun D. Singh | | 视频video | | | 概述 | New edition adding on new editors and featuring new chapters and contributors.Revamped table of contents to reflect the newest advances in ocular and adnexal lymphoma.Includes all new images, photos, | | 丛书名称 | Essentials in Ophthalmology | | 图书封面 |  | | 描述 | This book is a comprehensive source of authoritative information on the subject of ocular and adnexal lymphoma. It is a completely updated edition of its predecessor and is a conjoint effort of ocular oncologists, general oncologists, and pathologists. The book features contributions from around the world to ensure broad coverage of an evolving topic. .Chapters cover all aspects of ocular lymphomas, including clinical features, classification, epidemiology, diagnostic evaluation, biopsy techniques, histology and molecular pathology, staging procedures, and treatment methods. The emphasis throughout is on easy readability, and the layout ensures rapid retrieval of information. The book offers a clear distinction of what has been updated in the years since the first edition published, including entirely rewritten or revamped chapters. In order to convey fundamental concepts, numerous tables, clinical photographs, histopathologic microphotographs, and imaging studies (fluorescein and indocyanine angiograms, ultrasonograms, CT scans, and MR images) are included..Ocular and Adnexal Lymphoma. strives to cover new developments and innovations in ocular and adnexal lymphoma, providing the | | 出版日期 | Book 2023Latest edition | | 关键词 | ocular lymphoma; adnexal lymphoma; ocular oncology; intraocular lymphoma; intraocular therapy | | 版次 | 2 | | doi | https://doi.org/10.1007/978-3-031-24595-4 | | isbn_ebook | 978-3-031-24595-4Series ISSN 1612-3212 Series E-ISSN 2196-890X | | issn_series | 1612-3212 | | copyright | The Editor(s) (if applicable) and The Author(s), under exclusive license to Springer Nature Switzerl |
The information of publication is updating
|
|
发表于 2025-3-21 19:11:25
